Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

8.17
+0.05600.69%
Volume:465.15K
Turnover:3.79M
Market Cap:565.30M
PE:-11.29
High:8.20
Open:8.18
Low:8.07
Close:8.11
Loading ...
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 17, 2024

Major Issues Report

Form 8-K - Current report